<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">35178161</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1942-0994</ISSN><JournalIssue CitedMedium="Internet"><Volume>2022</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Oxidative medicine and cellular longevity</Title><ISOAbbreviation>Oxid Med Cell Longev</ISOAbbreviation></Journal><ArticleTitle>MPO/HOCl Facilitates Apoptosis and Ferroptosis in the SOD1<sup>G93A</sup> Motor Neuron of Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>8217663</StartPage><MedlinePgn>8217663</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8217663</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2022/8217663</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Oxidative stress and reactive oxygen species (ROS) are important in the pathogenesis of amyotrophic lateral sclerosis (ALS). Hypochlorous acid (HOCl) is a powerful oxidant of the reactive oxygen species (ROS) family. HOCl's role in the progress of ALS remains unclear due to the lack of an effective HOCl detection method. Cumulative evidence supports oxidative damage incurred by mutant hSOD1 contributing to motor neuron death; however, whether HOCl as well as its catalytic enzyme myeloperoxidase (MPO) function in the cell death of SOD1<sup>G93A</sup> ALS remains elusive.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The hSOD1<sup>WT</sup> and hSOD1<sup>G93A</sup> NSC-34 cell and SOD1<sup>G93A</sup> ALS mouse models were employed. With a novel fluorescent HOCl probe, HKOCl-3, we detected the expressions of HOCl and its catalytic enzyme, MPO, in the above models <i>in vitro</i> and <i>in vivo</i>. The regulation of MPO/HOCl by hSOD1<sup>G93A</sup> mutation and cell deaths by MPO/HOCl were also assayed, including apoptosis, ferroptosis, and autophagy.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our results showed that hSOD1<sup>G93A</sup> mutation promoted the activation of the MPO/HOCl pathway in SOD1<sup>G93A</sup> ALS cell models. The activation of MPO/HOCl pathways facilitated apoptosis and ferroptosis through increasing the Bax/Bcl-2 ratio and expression of caspase-3 or inhibiting the expressions of GPX4 and NQO1 and thus leading to irreversible lipid peroxidation. Overexpressed FSP1, a glutathione-independent suppressor, could ameliorate ferroptosis. <i>In vivo</i>, we demonstrated that the activation of the MPO/HOCl pathway occurred differently in motor neurons of the motor cortices, brain stems, and spinal cords in male and female SOD1<sup>G93A</sup> transgenic mice. In addition, inhibiting MPO improved the motor performance of SOD1<sup>G93A</sup> transgenic mice, as demonstrated by the rotarod test.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We concluded that aggregation of mutant hSOD1 proteins contributed to activation of the MPO/HOCl pathway, triggering apoptosis and ferroptosis in motor neuronal deaths and exerting impaired motor performance.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Jialing Peng et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Jialing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Jingrui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mo</LastName><ForeName>Jingjing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-4924-1430</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Oxid Med Cell Longev</MedlineTA><NlmUniqueID>101479826</NlmUniqueID><ISSNLinking>1942-0994</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.11.1.7</RegistryNumber><NameOfSubstance UI="C000628728">MPO protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.11.1.7</RegistryNumber><NameOfSubstance UI="D009195">Peroxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000079403" MajorTopicYN="N">Ferroptosis</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009195" MajorTopicYN="N">Peroxidase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare nothing.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>18</Day><Hour>5</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35178161</ArticleId><ArticleId IdType="pmc">PMC8845144</ArticleId><ArticleId IdType="doi">10.1155/2022/8217663</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wijesekera L. C., Leigh P. N. Amyotrophic lateral sclerosis. Orphanet Journal of Rare Diseases . 2009;4(1) doi: 10.1186/1750-1172-4-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-4-3</ArticleId><ArticleId IdType="pmc">PMC2656493</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosolini A. P., Sleigh J. N. Motor neuron gene therapy: lessons from spinal muscular atrophy for amyotrophic lateral sclerosis. Frontiers in Molecular Neuroscience . 2017;10:p. 405. doi: 10.3389/fnmol.2017.00405.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00405</ArticleId><ArticleId IdType="pmc">PMC5725447</ArticleId><ArticleId IdType="pubmed">29270111</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I. P., Tripathi V. B., et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science . 2008;319(5870):1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis S., Goizet C., Soulages A., Vallat J. M., Masson G. L. Genetics of amyotrophic lateral sclerosis: a review. Journal of the Neurological Sciences . 2019;399:217&#x2013;226. doi: 10.1016/j.jns.2019.02.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2019.02.030</ArticleId><ArticleId IdType="pubmed">30870681</ArticleId></ArticleIdList></Reference><Reference><Citation>Crippa V., Galbiati M., Boncoraglio A., et al. Motoneuronal and muscle-selective removal of ALS-related misfolded proteins. Biochemical Society Transactions . 2013;41(6):1598&#x2013;1604. doi: 10.1042/BST20130118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20130118</ArticleId><ArticleId IdType="pubmed">24256261</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Hyeon S. J., Im H., Ryu H., Kim Y., Ryu H. Astrocytes and microglia as non-cell autonomous players in the pathogenesis of ALS. Experimental neurobiology . 2016;25(5):233&#x2013;240. doi: 10.5607/en.2016.25.5.233.</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2016.25.5.233</ArticleId><ArticleId IdType="pmc">PMC5081469</ArticleId><ArticleId IdType="pubmed">27790057</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Lillo C., Jonsson P. A., et al. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron . 2004;43(1):5&#x2013;17. doi: 10.1016/j.neuron.2004.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.06.016</ArticleId><ArticleId IdType="pubmed">15233913</ArticleId></ArticleIdList></Reference><Reference><Citation>Vande Velde C., Miller T. M., Cashman N. R., Cleveland D. W. Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria. Proceedings of the National Academy of Sciences of the United States of America . 2008;105(10):4022&#x2013;4027. doi: 10.1073/pnas.0712209105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0712209105</ArticleId><ArticleId IdType="pmc">PMC2268797</ArticleId><ArticleId IdType="pubmed">18296640</ArticleId></ArticleIdList></Reference><Reference><Citation>Vande Velde C., McDonald K. K., Boukhedimi Y., et al. Misfolded SOD1 associated with motor neuron mitochondria alters mitochondrial shape and distribution prior to clinical onset. PLoS One . 2011;6(7, article e22031) doi: 10.1371/journal.pone.0022031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0022031</ArticleId><ArticleId IdType="pmc">PMC3136936</ArticleId><ArticleId IdType="pubmed">21779368</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr&#xec; M. T., D'Ambrosi N., Cozzolino M. Pathways to mitochondrial dysfunction in ALS pathogenesis. Biochemical and Biophysical Research Communications . 2017;483(4):1187&#x2013;1193. doi: 10.1016/j.bbrc.2016.07.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.07.055</ArticleId><ArticleId IdType="pubmed">27416757</ArticleId></ArticleIdList></Reference><Reference><Citation>Milo&#x161;evi&#x107; M., Mili&#x107;evi&#x107; K., Bo&#x17e;i&#x107; I., et al. Immunoglobulins G from sera of amyotrophic lateral sclerosis patients induce oxidative stress and upregulation of antioxidative system in BV-2 microglial cell line. Frontiers in Immunology . 2017;8(8) doi: 10.3389/fimmu.2017.01619.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01619</ArticleId><ArticleId IdType="pmc">PMC5703705</ArticleId><ArticleId IdType="pubmed">29218049</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon S. J., Lemberg K. M., Lamprecht M. R., et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell . 2012;149(5):1060&#x2013;1072. doi: 10.1016/j.cell.2012.03.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.03.042</ArticleId><ArticleId IdType="pmc">PMC3367386</ArticleId><ArticleId IdType="pubmed">22632970</ArticleId></ArticleIdList></Reference><Reference><Citation>Alim I., Caulfield J. T., Chen Y., et al. Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke. Cell . 2019;177(5):1262&#x2013;1279.e25. doi: 10.1016/j.cell.2019.03.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.03.032</ArticleId><ArticleId IdType="pubmed">31056284</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y. S., Lee D. H., Choudry H. A., Bartlett D. L., Lee Y. J. Ferroptosis-induced endoplasmic reticulum stress: crosstalk between ferroptosis and apoptosis. Molecular Cancer Research . 2018;16(7):1073&#x2013;1076. doi: 10.1158/1541-7786.MCR-18-0055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1541-7786.MCR-18-0055</ArticleId><ArticleId IdType="pmc">PMC6030493</ArticleId><ArticleId IdType="pubmed">29592897</ArticleId></ArticleIdList></Reference><Reference><Citation>Su L. J., Zhang J.-H., Gomez H., et al. Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis. Oxidative Medicine and Cellular Longevity . 2019;2019:13. doi: 10.1155/2019/5080843.5080843</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/5080843</ArticleId><ArticleId IdType="pmc">PMC6815535</ArticleId><ArticleId IdType="pubmed">31737171</ArticleId></ArticleIdList></Reference><Reference><Citation>McElhanon K. E., Bose C., Sharma R., Wu L., Awasthi Y. C., Singh S. P. Gsta4 null mouse embryonic fibroblasts exhibit enhanced sensitivity to oxidants: role of 4-hydroxynonenal in oxidant toxicity. Open Journal of Apoptosis . 2013;2(1):1&#x2013;11. doi: 10.4236/ojapo.2013.21001.</Citation><ArticleIdList><ArticleId IdType="doi">10.4236/ojapo.2013.21001</ArticleId><ArticleId IdType="pmc">PMC3864047</ArticleId><ArticleId IdType="pubmed">24353929</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Burrington C. M., Davenport S. K., et al. PKC&#x3b4; regulates hepatic triglyceride accumulation and insulin signaling in Leprdb/db mice. Biochemical and Biophysical Research Communications . 2014;450(4):1619&#x2013;1625. doi: 10.1016/j.bbrc.2014.07.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2014.07.048</ArticleId><ArticleId IdType="pubmed">25035929</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng D.-W., Lei Q., Zhu J.-Y., et al. Switching apoptosis to ferroptosis: metal-organic network for high-efficiency anticancer therapy. Nano Letters . 2017;17(1):284&#x2013;291. doi: 10.1021/acs.nanolett.6b04060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.nanolett.6b04060</ArticleId><ArticleId IdType="pubmed">28027643</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali I., Khan S. N., Chatzicharalampous C., Bai D., Abu-Soud H. M. Catalase prevents myeloperoxidase self-destruction in response to oxidative stress. Journal of Inorganic Biochemistry . 2019;197:p. 110706. doi: 10.1016/j.jinorgbio.2019.110706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinorgbio.2019.110706</ArticleId><ArticleId IdType="pubmed">31103890</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Veen B. S., de Winther M. P., Heeringa P. Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxidants &amp; Redox Signaling . 2009;11(11):2899&#x2013;2937. doi: 10.1089/ars.2009.2538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2009.2538</ArticleId><ArticleId IdType="pubmed">19622015</ArticleId></ArticleIdList></Reference><Reference><Citation>Aratani Y. Myeloperoxidase: its role for host defense, inflammation, and neutrophil function. Archives of Biochemistry and Biophysics . 2018;640:47&#x2013;52. doi: 10.1016/j.abb.2018.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2018.01.004</ArticleId><ArticleId IdType="pubmed">29336940</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray R. S., Katyal A. Myeloperoxidase: bridging the gap in neurodegeneration. Neuroscience and Biobehavioral Reviews . 2016;68:611&#x2013;620. doi: 10.1016/j.neubiorev.2016.06.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2016.06.031</ArticleId><ArticleId IdType="pubmed">27343997</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripps M. E., Huntley G. W., Hof P. R., Morrison J. H., Gordon J. W. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences of the United States of America . 1995;92(3):689&#x2013;693. doi: 10.1073/pnas.92.3.689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.92.3.689</ArticleId><ArticleId IdType="pmc">PMC42685</ArticleId><ArticleId IdType="pubmed">7846037</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M. E., Pu H., Chiu A. Y., et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science . 1994;264(5166):1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Leyton-Jaimes M. F., Kahn J., Israelson A. AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS. Proceedings of the National Academy of Sciences of the United States of America . 2019;116(29):14755&#x2013;14760. doi: 10.1073/pnas.1904665116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1904665116</ArticleId><ArticleId IdType="pmc">PMC6642395</ArticleId><ArticleId IdType="pubmed">31262807</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso R., del Valle J., Modol L., et al. Resveratrol improves motoneuron function and extends survival in SOD1G93A ALS mice. Neurotherapeutics . 2014;11(2):419&#x2013;432. doi: 10.1007/s13311-013-0253-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-013-0253-y</ArticleId><ArticleId IdType="pmc">PMC3996124</ArticleId><ArticleId IdType="pubmed">24414863</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravera S., Torazza C., Bonifacino T., et al. Altered glucose catabolism in the presynaptic and perisynaptic compartments of SOD1G93A mouse spinal cord and motor cortex indicates that mitochondria are the site of bioenergetic imbalance in ALS. Journal of Neurochemistry . 2019;151(3):336&#x2013;350. doi: 10.1111/jnc.14819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14819</ArticleId><ArticleId IdType="pubmed">31282572</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J. J., Wong N.-K., Lu M. Y., et al. HKOCl-3: a fluorescent hypochlorous acid probe for live-cell and in vivo imaging and quantitative application in flow cytometry and a 96-well microplate assay. Chemical Science . 2016;7(3):2094&#x2013;2099. doi: 10.1039/C5SC03855C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C5SC03855C</ArticleId><ArticleId IdType="pmc">PMC5968534</ArticleId><ArticleId IdType="pubmed">29899935</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceballos-Diaz C., Rosario A. M., Park H.-J., et al. Viral expression of ALS-linked ubiquilin-2 mutants causes inclusion pathology and behavioral deficits in mice. Molecular Neurodegeneration . 2015;10(1):p. 25. doi: 10.1186/s13024-015-0026-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-015-0026-7</ArticleId><ArticleId IdType="pmc">PMC4495639</ArticleId><ArticleId IdType="pubmed">26152284</ArticleId></ArticleIdList></Reference><Reference><Citation>Pramatarova A., Lagani&#xe8;re J., Roussel J., Brisebois K., Rouleau G. A. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. The Journal of Neuroscience . 2001;21(10):3369&#x2013;3374. doi: 10.1523/JNEUROSCI.21-10-03369.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-10-03369.2001</ArticleId><ArticleId IdType="pmc">PMC6762496</ArticleId><ArticleId IdType="pubmed">11331366</ArticleId></ArticleIdList></Reference><Reference><Citation>Doll S., Freitas F. P., Shah R., et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature . 2019;575(7784):693&#x2013;698. doi: 10.1038/s41586-019-1707-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1707-0</ArticleId><ArticleId IdType="pubmed">31634899</ArticleId></ArticleIdList></Reference><Reference><Citation>Bersuker K., Hendricks J. M., Li Z., et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature . 2019;575(7784):688&#x2013;692. doi: 10.1038/s41586-019-1705-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1705-2</ArticleId><ArticleId IdType="pmc">PMC6883167</ArticleId><ArticleId IdType="pubmed">31634900</ArticleId></ArticleIdList></Reference><Reference><Citation>Maki R. A., Holzer M., Motamedchaboki K., et al. Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-&#x3b1;-synuclein-A53T mouse model, correlating with increased nitration and aggregation of &#x3b1;-synuclein and exacerbation of motor impairment. Free Radical Biology &amp; Medicine . 2019;141:115&#x2013;140. doi: 10.1016/j.freeradbiomed.2019.05.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2019.05.033</ArticleId><ArticleId IdType="pmc">PMC6774439</ArticleId><ArticleId IdType="pubmed">31175983</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian R., Ding Y., Peng Y. Y., Lu N. Myeloperoxidase amplified high glucose-induced endothelial dysfunction in vasculature: role of NADPH oxidase and hypochlorous acid. Biochemical and Biophysical Research Communications . 2017;484(3):572&#x2013;578. doi: 10.1016/j.bbrc.2017.01.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2017.01.132</ArticleId><ArticleId IdType="pubmed">28131839</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzikas S., Schlak D., Sopova K., et al. Increased myeloperoxidase plasma levels in patients with Alzheimer's disease. Journal of Alzheimer's Disease . 2014;39(3):557&#x2013;564. doi: 10.3233/JAD-131469.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-131469</ArticleId><ArticleId IdType="pubmed">24217274</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockwell B. R., Jiang X. A physiological function for ferroptosis in tumor suppression by the immune system. Cell Metabolism . 2019;30(1):14&#x2013;15. doi: 10.1016/j.cmet.2019.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2019.06.012</ArticleId><ArticleId IdType="pmc">PMC6944065</ArticleId><ArticleId IdType="pubmed">31269423</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Y., Wang N., Liu N., Dong H. Lipid peroxidation and GPX4 inhibition are common causes for myofibroblast differentiation and ferroptosis. DNA and Cell Biology . 2019;38(7):725&#x2013;733. doi: 10.1089/dna.2018.4541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dna.2018.4541</ArticleId><ArticleId IdType="pubmed">31140862</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X., Ou Z., Chen R., et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology . 2016;63(1):173&#x2013;184. doi: 10.1002/hep.28251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.28251</ArticleId><ArticleId IdType="pmc">PMC4688087</ArticleId><ArticleId IdType="pubmed">26403645</ArticleId></ArticleIdList></Reference><Reference><Citation>An T., Shi P., Duan W., et al. Oxidative stress and autophagic alteration in brainstem of SOD1-G93A mouse model of ALS. Molecular Neurobiology . 2014;49(3):1435&#x2013;1448. doi: 10.1007/s12035-013-8623-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-013-8623-3</ArticleId><ArticleId IdType="pubmed">24390572</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci M., Spalloni A., Bartalucci A., et al. A systematic study of brainstem motor nuclei in a mouse model of ALS, the effects of lithium. Neurobiology of Disease . 2010;37(2):370&#x2013;383. doi: 10.1016/j.nbd.2009.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2009.10.017</ArticleId><ArticleId IdType="pubmed">19874893</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmieri A., Mento G., Calvo V., et al. Female gender doubles executive dysfunction risk in ALS: a case-control study in 165 patients. Journal of Neurology, Neurosurgery, and Psychiatry . 2015;86(5):574&#x2013;579. doi: 10.1136/jnnp-2014-307654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-307654</ArticleId><ArticleId IdType="pubmed">25063584</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney J., Fogh I., Westeneng H. J., et al. C9orf72 expansion differentially affects males with spinal onset amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry . 2017;88(4):281.1&#x2013;28281. doi: 10.1136/jnnp-2016-314093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-314093</ArticleId><ArticleId IdType="pubmed">27663272</ArticleId></ArticleIdList></Reference><Reference><Citation>McLeod V. M., Chiam M. D. F., Lau C. L., Rupasinghe T. W., Boon W. C., Turner B. J. Dysregulation of steroid hormone receptors in motor neurons and glia associates with disease progression in ALS mice. Endocrinology . 2020;161(9) doi: 10.1210/endocr/bqaa113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endocr/bqaa113</ArticleId><ArticleId IdType="pubmed">32621747</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerghet M., Skoff R. P., Bessert D., Zhang Z., Mullins C., Ghandour M. S. Proliferation and death of oligodendrocytes and myelin proteins are differentially regulated in male and female rodents. The Journal of Neuroscience . 2006;26(5):1439&#x2013;1447. doi: 10.1523/JNEUROSCI.2219-05.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2219-05.2006</ArticleId><ArticleId IdType="pmc">PMC6675481</ArticleId><ArticleId IdType="pubmed">16452667</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B. W., Jeong Y. E., Wong M., Martin L. J. DNA damage accumulates and responses are engaged in human ALS brain and spinal motor neurons and DNA repair is activatable in iPSC-derived motor neurons with SOD1 mutations. Acta Neuropathologica Communications . 2020;8(1) doi: 10.1186/s40478-019-0874-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0874-4</ArticleId><ArticleId IdType="pmc">PMC6995159</ArticleId><ArticleId IdType="pubmed">32005289</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogaert E., van Damme P., Poesen K., et al. VEGF protects motor neurons against excitotoxicity by upregulation of GluR2. Neurobiology of Aging . 2010;31(12):2185&#x2013;2191. doi: 10.1016/j.neurobiolaging.2008.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2008.12.007</ArticleId><ArticleId IdType="pubmed">19185395</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>